Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 3, 2007, Pages 383-384

  Pavan, M H P ^a   Velho, P E N F ^a   Vigani, A G ^a   Goncalves Jr F L ^a   Aoki, Francisco Hideo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Hepatitis C; Human immunodeficiency virus; Human papillomavirus; Pegylated interferon; Ribavirin

Indexed keywords

BCG VACCINE; EFAVIRENZ; FLUOROURACIL; LAMIVUDINE; LIQUID NITROGEN; NITRIC ACID; OZONE; PEGINTERFERON ALPHA2B; PODOPHYLLIN; RIBAVIRIN; TRICHLOROACETIC ACID; ZIDOVUDINE;

ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CONDYLOMA; CRYOTHERAPY; DRUG RESPONSE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OZONE THERAPY; PHYTOTHERAPY; SUPERINFECTION; TREATMENT DURATION; VERRUCA VULGARIS;

EID: 35448975240     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000300017     Document Type: Article

References (3)

1. Gerein V., Rastorguev E., Gerein J., et al. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up. Ann Otol Rhinl Laryngol 2005;114(6):463-71.
2. Purceli M.C.S.C., Jotz G.P., Miranda S.L., et al.The use of ribavirin in the treatment of recurrent respiratory papillomatosis (PRR). Acta AWHO 1996;15(1):33-6.
3. Gubinelli E., Posteraro P., Cocuroccia B., et al. Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin. J Dermatolog Treat 2003; 14(3):184-8.